Complete or incomplete percutaneous coronary revascularization in patients with unstable angina in stent era: Are early and one‐year results different?
- 19 November 2001
- journal article
- clinical trial
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 54 (4) , 448-453
- https://doi.org/10.1002/ccd.1309
Abstract
The aim of our study was to evaluate the impact of a strategy of incomplete revascularization by PTCA, with or without stent implantation, on clinical outcome of 208 consecutive patients (171 men) with unstable angina and multivessel coronary artery disease. Mean age of the group was 63.8 ± 10.3 years (range, 31–91). Complete and incomplete revascularization was achieved in 49 and 159 patients, respectively. A total of 226 stents were implanted in 172 patients (1.31 ± 0.65 stent per patient), equally distributed between the two groups. Left ventricular ejection fraction < 40% and total chronic coronary occlusions were significantly more frequent in patients with incomplete revascularization than in those with complete (P = 0.014 and 0.001, respectively). In‐hospital MACE occurred in 10% and 7.5% of patients with complete and incomplete revascularization, respectively (P = NS). By multivariate analysis, multiple stent implantation (OR, 5.44; 95% CI, 1.21–24.3), presence of thrombus in the treated lesion (OR, 6.3; 95% CI, 1.53–25.9), Braunwald class III (OR, 4.74; 95% CI, 1.08–20.8), and ad hoc PTCA (OR 4.51; 95% CI, 1.11–18.3) were significantly related to in‐hospital outcome. At 1‐year follow‐up, 11.3% and 11.5% of patients with complete and incomplete revascularization, respectively, had MACE. In all patients, diabetes (OR, 3.40; 95% CI, 1.09–10.58) and presence of thrombus in the treated lesion (OR, 3.48; 95% CI, 1.12–10.84) were significant predictors of 1‐year outcome by multivariate analysis. These results indicate that the strategy of incomplete revascularization in unstable angina patients with multivessel coronary disease does not expose them to a higher risk of death or other major ischemic events in comparison to those undergoing complete revascularization. Cathet Cardiovasc Intervent 2001;54:448–453.Keywords
This publication has 18 references indexed in Scilit:
- Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery?: The bypass angioplasty revascularization investigation (BARI)Journal of the American College of Cardiology, 1999
- Impact of postangioplasty restenosis on comparisons of outcome between angioplasty and bypass graftingThe American Journal of Cardiology, 1998
- Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty?Journal of the American College of Cardiology, 1993
- Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomesJournal of the American College of Cardiology, 1993
- Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985–1986 NHLBI PTCA Registry)The American Journal of Cardiology, 1992
- The degree of revascularization and outcome after multivessel coronary angioplastyAmerican Heart Journal, 1992
- Multivessel coronary angioplasty from 1980 to 1989: Procedural results and long-term outcomeJournal of the American College of Cardiology, 1990
- Prequtaneous transluminal angioplasty in patients with multivessel coronary disease: How important is complete revascularization for cardiac event-free survival?Journal of the American College of Cardiology, 1990
- Guidelines for percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1988
- Coronary angioplasty: A therapeutic option for symptomatic patients with two and three vessel coronary diseaseJournal of the American College of Cardiology, 1988